Mediators of Inflammation (Jan 2013)

IL-21 Modulates Release of Proinflammatory Cytokines in LPS-Stimulated Macrophages through Distinct Signaling Pathways

  • Su-nan Li,
  • Wei Wang,
  • Shou-peng Fu,
  • Jian-fa Wang,
  • Hong-mei Liu,
  • Shan-shan Xie,
  • Bing-run Liu,
  • Yang Li,
  • Qing-kang Lv,
  • Zhi-qiang Li,
  • Wen-jing Xue,
  • Bing-xu Huang,
  • Wei Chen,
  • Ju-xiong Liu

DOI
https://doi.org/10.1155/2013/548073
Journal volume & issue
Vol. 2013

Abstract

Read online

The aim of this study was to investigate the anti-inflammatory effect of IL-21 on LPS-induced mouse peritoneal macrophages. The results showed that IL-21 significantly inhibited LPS-induced mRNA expression of IL-1β, TNF-α, and IL-6 in macrophages, but not of IFN-γ, IL-10, CCL5, or CXCL2. ELISA analysis showed that IL-21 also suppressed LPS-induced production of TNF-α and IL-6 in culture supernatants. Western blot analysis showed that IL-21 clearly inhibited ERK and IκBα phosphorylation and NF-κB translocation in LPS-stimulated macrophages, but it increased STAT3 phosphorylation. Flow cytometric and Western blot analysis showed that IL-21 decreased M1 macrophages surface markers expression of CD86, iNOS, and TLR4 in LPS-stimulated cells. All results suggested that IL-21 decreases IL-6 and TNF-α production via inhibiting the phosphorylation of ERK and translocation of NF-κB and promotes a shift from the M1 to M2 macrophage phenotype by decreasing the expression of CD86, iNOS, and TLR4 and by increasing STAT3 phosphorylation in LPS-stimulated cells.